DAVID Bioinformatics
The Database for Annotation, Visualization and Integrated Discovery
DAVID Bioinformatics Resources 2008
National Institute of Allergy and Infectious Diseases (NIAID), NIH
DAVID Gene Report
Gene Report

Right-click and select 'Save Target As' to download results Download File
2860531 chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha) Related Genes Homo sapiens
SP_COMMENT PTM:N-terminal processed forms GRO-alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) are produced by proteolytic cleavage after secretion from peripheral blood monocytes., function:Has chemotactic activity for neutrophils. May play a role in inflammation and exerts its effects on endothelial cells in an autocrine fashion. In vitro, the processed forms GRO-alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) show a 30-fold higher chemotactic activity., similarity:Belongs to the intercrine alpha (chemokine CxC) family., subcellular location:Secreted.,
REFSEQ_PROTEIN NP_001502,
ENTREZ_GENE_SUMMARY Chemokines are a group of small (approximately 8 to 14 kD), mostly basic, structurally related molecules that regulate cell trafficking of various types of leukocytes through interactions with a subset of 7-transmembrane, G protein-coupled receptors. Chemokines also play fundamental roles in the development, homeostasis, and function of the immune system, and they have effects on cells of the central nervous system as well as on endothelial cells involved in angiogenesis or angiostasis. Chemokines are divided into 2 major subfamilies, CXC and CC, based on the arrangement of the first 2 of the 4 conserved cysteine residues; the 2 cysteines are separated by a single amino acid in CXC chemokines and are adjacent in CC chemokines. CXC chemokines are further subdivided into ELR and non-ELR types based on the presence or absence of a glu-leu-arg sequence adjacent and N terminal to the CXC motif.[supplied by OMIM],
REFSEQ_MRNA NM_001511,
GENPEPT_ACCESSION AAA03452, AAA35933, AAH11976, AAP35526, ABM84517, ABM85867, CAA31027, CAA38361, EAX05693, Genomic_DNA, Unassigned_DNA, mRNA,
GENE_SYMBOL Cxcl1,
GENE_NAME C-X-C motif chemokine 1, GRO-alpha(1-73), Growth-regulated alpha protein precursor, Growth-regulated alpha protein precursor (C-X-C motif chemokine 1) (Melanoma growth stimulatory activity) (MGSA) (Neutrophil-activating protein 3) (NAP-3) (GRO-alpha(1-73)) [Contains: GRO-alpha(4-73); GRO- alpha(5-73); GRO-alpha(6-73)], Melanoma growth stimulatory activity, Melanoma growth stimulatory activity alpha, Melanoma growth stimulatory activity alpha (Fragment), MgsA, NAP-3, Neutrophil-activating protein 3, chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha),
GENERIF_SUMMARY GRO-alpha levels in blood, quantities released from platelets ex vivo, and quantities released from SFFLRN stimulated platelets ex vivo were compared for preeclamptic and normal pregnancies., may play a role in the pathogenesis of endometriosis, possibly by chemoattraction and activation of neutrophils present in higher numbers in the peritoneal fluid of women with endometriosis, mediates angiogenesis in Kaposi's sarcoma, Eosinophils produce large amounts of the CXC chemokine GRO-alpha, which may be important during resolution of inflammation and may explain the interaction between eosinophils and certain tumors., The role of GROa in cultured nasal epithelial cells was studied for its ability to synthesize and deliver neutrophil chemotactic factors following TNF-alpha induction., Recombinant GROalpha induces articular chondrocyte hypertrophy and calcification through p38 MAP kinase and transglutaminase 2., expression of GRO-1 in 9 oral squamous cell carcinoma (OSCC) cell lines and 94 OSCC specimens; findings suggest a possible relationship between the expression level of GRO-1 and tumor progression, This suggests that GRO-alpha plays a role in the infiltration of neutrophils into the lesional skin and in bulla formation in linear IgA bullous dermatosis., KC (CXCL1) mRNA is regulated by functionally independent AU-rich sequence motifs, We propose that the concurrence of CXCR2 on oligodendrocytes and induced CXCL1 on hypertrophic astrocytes in MS provides a novel mechanism for recruitment of oligodendrocytes to areas of damage, an essential prerequisite for lesion repair., endothelin-1 (ET-1) induces CXCL1 and CXCL8 secretion in three human melanoma cell lines, CXCL1 released from prostaglandin E2-treated carcinoma cells induces microvascular endothelial cell migration and tube formation in vitro., IL-1beta- and TNF-alpha-stimulated expression of GRO-alpha from airway smooth muscle is regulated by independent pathways involving NF-kappaB activation and ERK and JNK pathways, LDL lipoprotein subunit L5 induces human umbilical vein endothelial cells (HUVEC) to express GRO-alpha., Gro-1 may be a therapeutic target as well as a diagnostic marker in ovarian cancer, Coexpression of fibulin-1 with GROalpha abrogates key aspects of the transformed phenotype, including colonic tumor formation in a murine xenograft model., GROalpha led to p38 MAPK activation in chondrocytes cultured in micromass but not as a high-density monolayer. This caused the downstream triggering of chondrocyte hypertrophy and apoptosis/anoikis following concurrence of matrix degrading activity., CX3CR1 and CX3CL1 mediate heterotypic anchorage of foam cells to coronary artery smooth muscle cells in the context of atherosclerosis, Inhibition of ERK decreased expression of Groa., PAR-2 plays a role in serine protease-mediated regulation of IL-8 and GRO-alpha in nasal epithelial cells and may be involved in the pathophysiology of rhinosinusitis.,
CHROMOSOME 4,
ENTREZ_GENE_ID 2919,
PIR_SUMMARY Has chemotactic activity for neutrophils. May play a role in inflammation and exerts its effects on endothelial cells in an autocrine fashion. In vitro, the processed forms GRO- alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) show a 30-fold higher chemotactic activity.,
UNIGENE Hs.789,
UNIREF100_ID UniRef100_P09341, UniRef100_Q6LD34,
PIR_NREF_ID NF00097962, NF00113946,
UNIPROT_ID GROA_HUMAN, Q6LD34_HUMAN,
CYTOBAND 4q21,



 Please cite the web site or Genome Biology 2003; 4(5):P3 within any publication that makes use of any methods inspired by DAVID.
                          

        

                 
Term of Service | Contact Us | Site Map